Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)
The summary for the Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44): The purpose of this initiative is to invite SBIR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally. Combination prevention modalities may be more desirable and lead to better adherence in the end user, especially among younger populations. A viable and effective combination prevention modality would be ideal and critical for these young women who are at risk for HIV and who desire protection against pregnancy.
| Federal Grant Title: | Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health Income Security and Social Services |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-HD-18-033 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.865 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | January 10th, 2018 |
| Original Application Deadline: | January 10th, 2018 |
| Posted Date: | November 6th, 2017 |
| Creation Date: | November 6th, 2017 |
| Archive Date: | February 15th, 2018 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | November 6th, 2017 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-18-033.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical...
- • Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial No...
- • Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P5...
- • Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional...
- • Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
- • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- More Grants from the National Institutes of Health
- • Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial...
- • Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC...
- • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
- • Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal ...
- • PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine...
